17/02/2026
Dynamic42 Appoints Wolfgang Kintzel as Strategic Advisor
Dynamic42 is pleased to announce that internationally experienced life‑science executive Wolfgang Kintzel has joined the company as a Strategic Advisor. With more than 35 years of leadership experience across biotechnology, diagnostics and medical technology, Wolfgang will support Dynamic42 in scaling its business model and preparing for entry into the US market.
The Organ‑on‑Chip market is undergoing rapid expansion, driven by growing demand for human‑relevant, animal‑free models in preclinical research and drug development. Market analyses indicate that the global sector could grow to more than USD 3.2 billion by 2034.
Over the past months, Wolfgang has already contributed as a strategic sparring partner, advising on product positioning, commercialization and internationalization. His expertise will provide important momentum for Dynamic42’s growth strategy as the company focuses on industrial scaling and systematic international expansion.
"With Wolfgang Kintzel, we are gaining an extremely experienced business consultant for our team. His market knowledge and international experience are an important lever for scaling our organ-based technologies globally." says Knut Rennert, co-founder and CEO of Dynamic42.
Dynamic42 looks forward to advancing its mission of becoming a leading global provider of human Organ‑on‑Chip models.
